Literature DB >> 12430881

Structure and function of human fibrinogen inferred from dysfibrinogens.

Michio Matsuda1, Teruko Sugo.   

Abstract

Fibrinogen is a 340-kDa plasma protein that is composed of two identical molecular halves, each consisting of three non-identical subunit polypeptides designated as A alpha, B beta- and gamma-chains held together by multiple disulfide bonds. Fibrinogen has a trinodular structure, i.e., one central E domain comprizing the amino-terminal regions of paired individual three polypeptides, and two identical outer D domains. These three nodules are linked by two coiled-coil regions [1,2]. After activation with thrombin, a tripeptide segment consisting of Gly-Pro-Arg is exposed at the amino-terminus of each alpha-chain residing at the center of the E domain and combines with its complementary binding site, called the 'a' site, residing in the carboxyl-terminal region of the gamma-chain in the outer D domain of another molecule. By crystallographic analysis [3], the alpha-amino group of alpha Gly-1 is shown to be juxtaposed between the carboxyl group of gamma Asp-364 and the carboxyamide of Gln-329 in the 'a' site. Half molecule-staggered, double-stranded fibrin protofibrils are thus formed [4,5]. Upon abutment of two adjacent D domains on the same strand, D-D self association takes place involving Arg-275, Tyr-280 and Ser-300 of the gamma-chain on the surface of the abutting two D domains [3]. Thereafter, carboxyl-terminal regions of the fibrin a-chains are thought to be untethered and interact with those of other protofibrils leading to the formation of thick fibrin bundles and interwoven networks after appropriate branching [6-9]. Although many enigmas still remain regarding the mechanisms of these molecular interactions, fibrin assembly proceeds in a highly ordered fashion. In my talk, I would like to discuss these molecular interactions of fibrinogen and fibrin based on the up-date data provided by analyses of normal as well as hereditary dysfibrinogens, particularly in the latter by introducing representative molecules at each step of fibrin clot formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430881     DOI: 10.1007/bf03165284

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  66 in total

1.  Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.

Authors:  V C Yee; K P Pratt; H C Côté; I L Trong; D W Chung; E W Davie; R E Stenkamp; D C Teller
Journal:  Structure       Date:  1997-01-15       Impact factor: 5.006

2.  Electrospray ionization mass spectrometry identification of fibrinogen Banks Peninsula (gamma280Tyr-->Cys): a new variant with defective polymerization.

Authors:  A P Fellowes; S O Brennan; H J Ridgway; D C Heaton; P M George
Journal:  Br J Haematol       Date:  1998-04       Impact factor: 6.998

3.  Evidence for four different polymerization sites involved in human fibrin formation.

Authors:  S A Olexa; A Z Budzynski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

4.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.

Authors:  G Spraggon; S J Everse; R F Doolittle
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

5.  A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing.

Authors:  Y Wada; K Niwa; H Maekawa; S Asakura; T Sugo; M Nakanishi; G Auerswald; M Popp; M Matsuda
Journal:  Thromb Haemost       Date:  1993-09-01       Impact factor: 5.249

6.  Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.

Authors:  P Reber; M Furlan; A Henschen; H Kaudewitz; T Barbui; P Hilgard; G G Nenci; M Berrettini; E A Beck
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

7.  Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA).

Authors:  J Koopman; F Haverkate; J Grimbergen; R Egbring; S T Lord
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

8.  Hereditary dysfibrinogenemia in a patient with thrombotic disease.

Authors:  N Carrell; D A Gabriel; P M Blatt; M E Carr; J McDonagh
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

9.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.

Authors:  A P Laudano; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

10.  Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.

Authors:  N Yoshida; S Terukina; M Okuma; M Moroi; N Aoki; M Matsuda
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

View more
  4 in total

1.  Detection of a unique fibrinolytic enzyme in Aeromonas sp. JH1.

Authors:  Han-Young Cho; Min Jeong Seo; Jeong Uck Park; Byoung Won Kang; Gi-Young Kim; Woo Hong Joo; Young-Choon Lee; Young-Su Cho; Yong Kee Jeong
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

2.  A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants.

Authors:  Karl G Sylvester; Xuefeng B Ling; G Y Liu; Zachary J Kastenberg; Jun Ji; Zhongkai Hu; Sihua Peng; Ken Lau; Fizan Abdullah; Mary L Brandt; Richard A Ehrenkranz; Mary Catherine Harris; Timothy C Lee; Joyce Simpson; Corinna Bowers; R Lawrence Moss
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

3.  Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; William R Auger; Peter F Fedullo; Virgil L Woods
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

4.  Analysis of risk factors for perioperative hidden blood loss in unilateral biportal endoscopic spine surgery: a retrospective multicenter study.

Authors:  Haosheng Wang; Kai Wang; Bin Lv; Wenle Li; Tingting Fan; Jianwu Zhao; Mingyang Kang; Rongpeng Dong; Yang Qu
Journal:  J Orthop Surg Res       Date:  2021-09-15       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.